特瑞氟米特
医学
多发性硬化
奥图穆马
单克隆抗体
CD20
药理学
皮肤病科
抗体
免疫学
芬戈莫德
作者
Stephen L. Hauser,Amit Bar‐Or,Jeffrey Cohen,Gıancarlo Comı,Jorge Correale,Patricia K. Coyle,Anne H. Cross,de Sèze,David Leppert,Xavier Montalbán,Krzysztof Selmaj,Heinz Wiendl,Cécile Kerloëguen,Roman Willi,Bingbing Li,Algirdas Kakarieka,Davorka Tomic,Alexandra Goodyear,Ratnakar Pingili,Dieter A. Häring
标识
DOI：10.1056/nejmoa1917246
摘要
Ofatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and B-cell activation. The relative effects of these two drugs in patients with multiple sclerosis are not known.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
tuanheqi
小青椒
zcl
Smar_zcl
changping
star
wlscj
lalala
风中冰香
个性的紫菜
GingerF
Tourist
哈基米德
凤凰
那时花开
小杭76
彭于彦祖
eric888
chenqiumu
菠菜
机灵班
xxfsx
LPPQBB
皖公网安备34019202002308
